Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
The Biochemical Journal|May 29, 2025
LRRK2-mediated mitochondrial dysfunction in Parkinson's diseaseSilas A Buck, Laurie H SandersAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisSilas A Buck, John F Ervin, Shih-Hsiu Jerry Wang, et al.Biorxiv : the Preprint Server for Biology|July 15, 2025
Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathiesSilas A Buck, Tuyana Malankhanova, Eileen B Ma, et al.Neurobiology of Learning and Memory|August 2, 2020
Exposure to elevated embryonic kynurenine in rats: Sex-dependent learning and memory impairments in adult offspringSilas A Buck, Annalisa M Baratta, Ana PocivavsekFree Radical Biology & Medicine|January 19, 2013
Oxidative damage to macromolecules in human Parkinson disease and the rotenone modelLaurie H Sanders, J Timothy GreenamyreActa Neuropathologica|October 23, 2025
LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathiesSilas A Buck, Tuyana Malankhanova, Samuel Strader, et al.Biorxiv : the Preprint Server for Biology|April 10, 2026
Rab12 is a regulator of mitophagy and mitochondrial homeostasisTara Richbourg, Alex George, Anas Bitar, et al.Journal of Neuroscience Research|February 13, 2020
DNA damage and repair in Parkinson's disease: Recent advances and new opportunitiesClaudia P Gonzalez-Hunt, Laurie H SandersCurrent Environmental Health Reports|October 6, 2022
Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants - Implications for Parkinson's DiseaseAshley Adamson, Silas A Buck, Zachary Freyberg, et al.The FEBS Journal|July 24, 2020
Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuseSilas A Buck, Mary M Torregrossa, Ryan W Logan, et al.Pageof 6